Showing results (611-620 of 2,903) with videos related to
Sort By:
Pageof 291
Cancer Gene Therapy|April 4, 2015
BCR/ABL oncogene-induced PI3K signaling pathway leads to chronic myeloid leukemia pathogenesis by impairing immuno-modulatory function of hemangioblastsQ Li, Y Wu, S Fang, et al.Cancer Gene Therapy|July 29, 2020
Downregulation of SBF2-AS1 functions as a tumor suppressor in clear cell renal cell carcinoma by inhibiting miR-338-3p-targeted ETS1Xiuqin Yang, Yuanyuan Zhang, Haiying FanCancer Gene Therapy|April 11, 2015
Inhibition of pulmonary cancer progression by epidermal growth factor receptor-targeted transfection with Bcl-2 and survivin siRNAsY K Lee, T S Lee, I H Song, et al.Cancer Gene Therapy|July 14, 2020
HDAC3-dependent transcriptional repression of FOXA2 regulates FTO/m6A/MYC signaling to contribute to the development of gastric cancerZhi Yang, Xiaodi Jiang, Zhenghou Zhang, et al.Cancer Gene Therapy|July 4, 2020
MicroRNA-375 represses tumor angiogenesis and reverses resistance to sorafenib in hepatocarcinomaDong Li, Tao Wang, Fei-Fan Sun, et al.Cancer Gene Therapy|July 8, 2020
Bone marrow stromal cells-derived microRNA-181-containing extracellular vesicles inhibit ovarian cancer cell chemoresistance by downregulating MEST via the Wnt/β-catenin signaling pathwayZhengyi Ruan, Lili Lu, Li Zhang, et al.Cancer Gene Therapy|November 10, 2012
Combination of vinblastine and oncolytic herpes simplex virus vector expressing IL-12 therapy increases antitumor and antiangiogenic effects in prostate cancer modelsB J Passer, T Cheema, S Wu, et al.Cancer Gene Therapy|October 6, 2012
Synthetic DNA immunogen encoding hepatitis B core antigen drives immune response in liverN Obeng-Adjei, D K Choo, J Saini, et al.Cancer Gene Therapy|November 9, 2022
Rational pemetrexed combined with CIK therapy plus anti-PD-1 mAbs administration sequence will effectively promote the efficacy of CIK therapy in non-small cell lung cancerShaochuan Liu, Yuan Meng, Liang Liu, et al.Cancer Gene Therapy|November 12, 2022
EZH1/2 as targets for cancer therapyRan An, Yu-Qing Li, Yue-Ling Lin, et al.Pageof 291